Reported 780,145 shares, down 8,876 (1.1%) from the prior quarter.
Reported value 0.7%; share count -1.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 23613000 |
| 2022-03-31 | 27428000 |
| 2022-06-30 | 26374000 |
| 2022-09-30 | 27674000 |
| 2022-12-31 | 4060897 |
| 2023-03-31 | 3821778 |
| 2023-06-30 | 5055882 |
| 2023-09-30 | 4038984 |
| 2023-12-31 | 5193648 |
| 2024-03-31 | 12212447 |
| 2024-06-30 | 9719713 |
| 2024-09-30 | 15908620 |
| 2024-12-31 | 10291822 |
| 2025-03-31 | 3495363 |
| 2025-06-30 | 3518454 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2025 | Reduced | 0 | -780,145 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | Reduced | 780,145 | -8,876 (-1.1%) | < 0.01% | $3,518,454 | 2025-08-14 | |
| Q1 2025 | Reduced | 789,021 | -525,388 (-40.0%) | < 0.01% | $3,495,363 | 2025-05-15 | |
| Q4 2024 | Added | 1,314,409 | +104,628 (8.6%) | < 0.01% | $10,291,822 | 2025-02-14 | |
| Q3 2024 | Added | 1,209,781 | +405,169 (50.4%) | < 0.01% | $15,908,620 | 2024-11-14 | |
| Q2 2024 | Added | 804,612 | +53,539 (7.1%) | < 0.01% | $9,719,713 | 2024-08-14 | |
| Q1 2024 | Reduced | 751,073 | -10,459 (-1.4%) | < 0.01% | $12,212,447 | 2024-05-15 | |
| Q4 2023 | Added | 761,532 | +20,434 (2.8%) | < 0.01% | $5,193,648 | 2024-02-14 | |
| Q3 2023 | Reduced | 741,098 | -3,509 (-0.5%) | < 0.01% | $4,038,984 | 2023-11-14 | |
| Q2 2023 | Reduced | 744,607 | -18,223 (-2.4%) | < 0.01% | $5,055,882 | 2023-08-14 | |
| Q1 2023 | Reduced | 762,830 | -69,321 (-8.3%) | < 0.01% | $3,821,778 | 2023-05-15 | |
| Q4 2022 | Reduced | 832,151 | -1,086,988 (-56.6%) | < 0.01% | $4,060,897 | 2023-02-14 | |
| Q3 2022 | Added | 1,919,139 | +175,997 (10.1%) | < 0.01% | $27,674,000 | 2022-11-15 | |
| Q2 2022 | Reduced | 1,743,142 | -565,640 (-24.5%) | < 0.01% | $26,374,000 | 2022-08-15 | |
| Q1 2022 | Added | 2,308,782 | +852,112 (58.5%) | < 0.01% | $27,428,000 | 2022-05-16 | |
| Q4 2021 | Added | 1,456,670 | +124,727 (9.4%) | < 0.01% | $23,613,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
115 managers reported Y-MABS THERAPEUTICS INC for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | Unchanged | 4,236,346 | 0 | 0.82% | $19,105,920 | 6 qtrs |
| ACORN CAPITAL ADVISORS LLC | Added | 3,418,995 | +183,608 | 10.09% | $15,419,668 | 3 qtrs |
| BlackRock Inc | Reduced | 2,748,077 | -153,948 | < 0.01% | $12,393,829 | 4 qtrs |
| Caligan Partners LP | Unchanged | 2,342,609 | 0 | 2.03% | $10,565,167 | 8 qtrs |
| Sofinnova Investments Inc | Unchanged | 2,194,278 | 0 | 0.61% | $9,896,194 | 28 qtrs |
| VANGUARD GROUP INC | Reduced | 1,943,285 | -3,224 | < 0.01% | $8,764,215 | 28 qtrs |
| Polar Capital Holdings Plc | Reduced | 1,789,800 | -41,200 | 0.04% | $8,071,998 | 19 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 848,461 | -1,039 | < 0.01% | $3,827,252 | 27 qtrs |
| STATE STREET CORPORATION This report | Reduced | 780,145 | -8,876 | < 0.01% | $3,518,454 | 27 qtrs |
| BOOTHBAY FUND MANAGEMENT LLC | Unchanged | 693,693 | 0 | 0.06% | $3,128,555 | 8 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 740,122
- Shared
- 0
- None
- 40,023
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.